Moderna stock kpis
Want to see MRNA full AI Analyst Report?
Revenue by Segment
In Q2 2026, Moderna reported revenue by segment of $94.00M (Product Sales) and $51.00M (Grant and Collaboration).
Breaks down revenue across different business areas, revealing which segments are driving growth and how diversified Moderna's income streams are, indicating stability and strategic focus.
Product sales collapsed from the pandemic peak and moved into a lower, more volatile band — punctuated by periodic rebounds tied to international supply deals and new approvals — while grant/collaboration income is immaterial and steady. Management’s Q1 commentary confirms the rebound is commercially driven (mostly international) but fragile: guidance assumes only modest full‑year growth and Q2 is expected weak. For investors, the story has shifted from COVID tailwind to execution risk — durability of new product uptake, regulatory timing, and partner rollouts will determine whether product revenue stabilizes or reverts lower.
MRNA Revenue by Segment
| Period | Product Sales | Grant and Collaboration |
|---|---|---|
| Q2 2026Jun 30, 2026 | $94.00M | $51.00M |
| Q1 2026Mar 31, 2026 | $352.00M | $37.00M |
| Q4 2025Dec 31, 2025 | $645.00M | $33.00M |
| Q3 2025Sep 30, 2025 | $973.00M | $43.00M |
| Q2 2025Jun 30, 2025 | $114.00M | $28.00M |
| Q1 2025Mar 31, 2025 | $86.00M | $22.00M |
| Q4 2024Dec 31, 2024 | $938.00M | $28.00M |
| Q3 2024Sep 30, 2024 | $1.82B | $42.00M |
| Q2 2024Jun 30, 2024 | $184.00M | $57.00M |
| Q1 2024Mar 31, 2024 | $167.00M | $0.00 |
| Q4 2023Dec 31, 2023 | $2.79B | $18.00M |
| Q3 2023Sep 30, 2023 | $1.76B | $74.00M |
| Q2 2023Jun 30, 2023 | $293.00M | $51.00M |
| Q1 2023Mar 31, 2023 | $1.83B | $34.00M |
| Q4 2022Dec 31, 2022 | $4.89B | $225.00M |
| Q3 2022Sep 30, 2022 | $3.12B | $244.00M |
| Q2 2022Jun 30, 2022 | $4.53B | $218.00M |
| Q1 2022Mar 31, 2022 | $5.92B | $141.00M |
| Q4 2021Dec 31, 2021 | $6.93B | $276.00M |
| Q3 2021Sep 30, 2021 | $4.81B | $159.00M |
| Q2 2021Jun 30, 2021 | $4.20B | $157.00M |
| Q1 2021Mar 31, 2021 | $1.73B | $204.00M |
| Q4 2020Dec 31, 2020 | $199.87M | $370.22M |
| Q3 2020Sep 30, 2020 | $0.00 | $157.91M |
| Q2 2020Jun 30, 2020 | $0.00 | $67.00M |
| Q1 2020Mar 31, 2020 | $0.00 | $8.39M |

